Prog Neuropsychopharmacol Biol Psychiatry. 2016 Nov 23. pii: S0278-5846(16)30252-4. doi: 10.1016/j.pnpbp.2016.11.005.
[Epub ahead of print]
Abstract
This study investigated the effects of cannabidiol (CBD), a non-psychotomimetic phytochemical present in Cannabis sativa, on the cognitive and emotional impairments induced by bilateral common carotid artery occlusion (BCCAO) in mice. Using a multi-tiered behavioral testing battery during 21days, we found that BCCAO mice exhibited long-lasting functional deficits reflected by increase in anxiety-like behavior (day 9), memory impairments (days 12-18) and despair-like behavior (day 21). Short-term CBD 10mg/kg treatment prevented the cognitive and emotional impairments, attenuated hippocampal neurodegeneration and white matter (WM) injury, and reduced glial response that were induced by BCCAO. In addition, ischemic mice treated with CBD exhibited an increase in the hippocampal brain derived neurotrophic factor (BDNF) protein levels. CBD also stimulated neurogenesis and promoted dendritic restructuring in the hippocampus of BCCAO animals. Collectively, the present results demonstrate that short-term CBD treatment results in global functional recovery in ischemic mice and impacts multiple and distinct targets involved in the pathophysiology of brain ischemic injury.
Copyright © 2016. Published by Elsevier Inc.
KEYWORDS:
Bilateral common carotid arteries occlusion; Cannabidiol; Neuroplasticity; Neuroprotection; White matter
- PMID: 27889412
- DOI: 10.1016/j.pnpbp.2016.11.005
- [PubMed – as supplied by publisher]
